Soleno Therapeutics (SLNO)

• Market cap: $3.42B
• 1 day: 0.8%
• 5 days: 5.57%
• 1 month: 25.6%
• 3 months: -22.34%
• 6 months: -8.19%
• Year to date: 40.6%
• 1 year: 19.33%
• 5 years: 117.5%
• 10 years: -59.77%
• Sector: Healthcare
• Industry: Biotechnology

About: Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Employees: 133